Michele Bellandi
Amministratore Delegato presso Vertex Pharmaceuticals (France) SAS
Posizioni attive di Michele Bellandi
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Vertex Pharmaceuticals (U.K.) Ltd.
 Vertex Pharmaceuticals (U.K.) Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2011, Vertex Pharmaceuticals (U.K.) Ltd. is a subsidiary of Vertex Pharmaceuticals, Inc. that engages in research and experimental development on natural science. The company is based in London, UK. | Direttore/Membro del Consiglio | 15/10/2018 | - |
Vertex Pharmaceuticals (France) SAS
 Vertex Pharmaceuticals (France) SAS Pharmaceuticals: MajorHealth Technology Part of Vertex Pharmaceuticals, Inc., Vertex Pharmaceuticals (France) SAS develops and manufactures pharmaceutical products. The company is based in Paris, France. The CEOs are Michele Bellandi, Jonathan Oppenheim. The French company was founded in 2011. | Amministratore Delegato | 11/06/2021 | - |
Storia della carriera di Michele Bellandi
Precedenti posizioni note di Michele Bellandi
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Amryt Pharma Holdings Ltd.
 Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | - | 31/03/2017 |
Statistiche
Distribuzione geografica
| Regno Unito | 3 |
| Francia | 2 |
Posizioni
| Corporate Officer/Principal | 1 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Settori
| Health Technology | 3 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 3 |
|---|---|
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Health Technology |
Vertex Pharmaceuticals (U.K.) Ltd.
Vertex Pharmaceuticals (U.K.) Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2011, Vertex Pharmaceuticals (U.K.) Ltd. is a subsidiary of Vertex Pharmaceuticals, Inc. that engages in research and experimental development on natural science. The company is based in London, UK. | Commercial Services |
Vertex Pharmaceuticals (France) SAS
Vertex Pharmaceuticals (France) SAS Pharmaceuticals: MajorHealth Technology Part of Vertex Pharmaceuticals, Inc., Vertex Pharmaceuticals (France) SAS develops and manufactures pharmaceutical products. The company is based in Paris, France. The CEOs are Michele Bellandi, Jonathan Oppenheim. The French company was founded in 2011. | Health Technology |
- Borsa valori
- Insiders
- Michele Bellandi
- Esperienza